Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

BACKGROUND: Combining different cancer treatments represents a promising strategy to improve the therapeutic outcome for lung cancer patients with or without druggable gene alterations. METHODS: We previously developed a polyethylene glycol-based (PEG-based) immunostimulatory nanocarrier (PEG(2k)-Fm...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Dingwei, Zhai, Jianxue, Yang, Jianjun, Wu, Hua, Jiang, Jianjun, Dong, Xiaoying, Passaro, Antonio, Aramini, Beatrice, Rao, Shuan, Cai, Kaican
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947404/
https://www.ncbi.nlm.nih.gov/pubmed/33718033
http://dx.doi.org/10.21037/tlcr-21-144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947404/
https://www.ncbi.nlm.nih.gov/pubmed/33718033
http://dx.doi.org/10.21037/tlcr-21-144

Ejemplares similares